Patent · US Revoked

Medical device for administering anti-IL-23 antibodies

US11939375B2 · kind B2 · utility

0Cited by
24References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2021
Grant dateMar 26, 2024
Priority date
Expiry dateJul 1, 2042

Classification

  • Technology area (CPC —)General

Abstract

A human anti-IL-23p19 antibody, including isolated nucleic acids that encode at least one anti-IL-23p19 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.